Effect of Covid-19 Epidemic on Primary PCI and Prognosis in Patients With Acute STEMI
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- all-cause death
研究概览
简要总结
The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. It is necessary to study the treatment of STEMI patients in the real world under the influence of the epidemic,which provide effective suggestions and strategies for emergency and severe treatment.
详细描述
The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. The patients' prognosis is poor because the epidemic situation runs on medical resources, delays the diagnosis and treatment of other diseases such as cardiovascular diseases, and the patients' willingness to see a doctor is reduced. In particular, the delay in the treatment of STEMI, which needs PCI treatment, will cause more damage to the patients. It is necessary to study the treatment of STEMI patients in the real world under the influence of the epidemic. In this study, STEMI patients who experienced emergency PCI treatment after the covid-19 outbreak in 2020 were included, and compared with the data of the same period in 2019,we will analyze the pre hospital treatment time, vascular opening time,and the major cardiovascular adverse events, which provide effective suggestions and strategies for emergency and severe treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Cross Sectional
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Continuous inclusion of patients with definite diagnosis of acute ST segment elevation myocardial infarction and emergency PCI intervention.
排除标准
- •Febrile patients, patients with severe infection,
- •ST segment elevation myocardial infarction during hospitalization,
- •Patients who could not cooperate with each other.
结局指标
主要结局
all-cause death
时间窗: 1 year
death caused by all reason
MACE (major adverse cardiovascular events)
时间窗: 1 year
cardiovascular death, re-infarction, malignant arrhythmia,heart failure, revascularization, and stroke
次要结局
未报告次要终点
研究者
Hongwei Li, MD
professor
Beijing Friendship Hospital
